Target intelligence / Profile preview

Bacterial 50S ribosomal subunit and microbial DNA

Molecular classification
Ribonucleoprotein complex, Nucleic acid
01

Overview

This target entry represents a composite of two distinct bacterial components: the 50S ribosomal subunit and microbial DNA. The 50S ribosomal subunit is the larger component of the bacterial 70S ribosome, primarily composed of 23S and 5S ribosomal RNA (rRNA) and associated proteins. It serves as the site for peptidyl transferase activity, which is essential for the elongation of polypeptide chains during protein translation (StatPearls, 2023). Various antibiotic classes, such as macrolides and oxazolidinones, target the 50S subunit to arrest bacterial growth by halting protein synthesis (NCBI, 2022). Microbial DNA, conversely, is the genetic material of the bacterium and is targeted by agents that either cause direct structural damage or inhibit enzymes required for DNA maintenance. For example, nitroimidazoles like metronidazole cause DNA strand breaks, while fluoroquinolones inhibit DNA gyrase and topoisomerase IV, effectively preventing DNA replication and transcription (PubMed, 2021; PubChem, 2024). While both are critical therapeutic targets for treating bacterial infections, they are structurally and functionally unrelated, and their combination into a single target designation is non-standard in pharmacological classification.

Other names
50S ribosomeBacterial 50S subunitMicrobial deoxyribonucleic acid23S ribosomal RNABacterial genome
02

Mechanism of action

Inhibition of protein synthesis by binding to the 23S rRNA of the 50S subunit to block the exit tunnel or peptidyl transferase center; induction of DNA strand breakage or inhibition of DNA topoisomerases (DNA gyrase and Topoisomerase IV) to prevent DNA replication and transcription.

03

Biological functions

Protein synthesisTranslation elongationPeptidyl transferase activityGenetic information storageDNA replicationTranscription
04

Disease associations

InfectionBacterial infectionSepsis
05

Safety considerations

Antimicrobial resistanceDisruption of the human microbiomeMitochondrial toxicity (due to 50S similarity to mitochondrial ribosomes)QT prolongationGastrointestinal distressClostridioides difficile infection
06

Interacting drugs

Azithromycin

8 more in the full profile.

07

Biomarkers

Minimum inhibitory concentration (MIC)C-reactive protein (CRP)ProcalcitoninBacterial DNA load (PCR)

Beyond the preview

Go deeper on Bacterial 50S ribosomal subunit and microbial DNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial 50S ribosomal subunit and microbial DNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call